Phaseline

Targets › FXI

FXI: drug programs, companies and trials

1 program from 1 company in 1 trial: 1 Phase 1; Cardiovascular; next expected readout Mar 2028.

Open in Phaseline: the race on FXI, likelihood bands and readouts

Programs

CompanyDrugTargetsHighest phaseConditionsNext expected readout
City TherapeuticsCITY-FXI
siRNA targeting Factor XI
FXIPhase 1Factor V LeidenMar 2028

Conditions

Factor V Leiden (1)

Modalities

small molecule (1)

Companies

City Therapeutics (1)

Related targets

–

Programs group each company's trials by drug; targets and mechanisms come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood is in the app.